Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-07-18 to 2023-07-19
Current total value of award: $892.8
Description: 4561554371!ORALAIR 300 IR SUBLINGUAL TAB 30S